diprafenone has been researched along with Anomalous Ventricular Excitation Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geiger, M; Kuck, KH; Kunze, KP; Schlüter, M | 1 |
| Beermann, J; Gerckens, U; Lüderitz, B; Manz, M | 1 |
2 other study(ies) available for diprafenone and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Diprafenone for treatment of Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Electric Stimulation; Electrocardiography; Electroencephalography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Refractory Period, Electrophysiological; Tachycardia; Wolff-Parkinson-White Syndrome | 1989 |
[Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle of His; Cardiomyopathy, Dilated; Coronary Disease; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Tachycardia; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1986 |